Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.
Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.
The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.
Publications found:
1,364
Sort by:
Global Dermatology Partnering 2014-2020: Deal trends, players and financials
US$ 3,495.00
... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...
April 2020
350 pages
Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global forecasts to 2025
US$ 5,650.00
... following pointers: Market Penetration: Comprehensive information on the product portfolios of top players in the digital therapeutics market. The report analyzes the digital therapeutics market by application, sales channel, and region Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the digital therapeutics market ...
March 2020
166 pages
Digital Therapeutics: A New Age Medicine
US$ 2,500.00
REPORT SCOPE: The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanc...
March 2020
13 pages
Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
This report can be delivered to the clients within 48 Business Hours The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, ac...
March 2020
100 pages
Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report By Therapy Type (Cell, CAR-T, Gene Therapy, Stem Cell, Non-stem Cell), By Region, And Segment Forecasts, 2020 - 2026
US$ 5,950.00
The global advanced therapy medicinal products market size is expected to reach USD 9.6 billion by 2026, expanding at a CAGR of 17.4% over the forecast period, according to a new report published by G...
February 2020
140 pages
Dermatologicals in South Africa
US$ 990.00
... associated with a lack of hygiene or a... Euromonitor International's Dermatologicals in South Africa report offers a comprehensive guide to the size and shape ... Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical ...
February 2020
22 pages
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026
US$ 3,000.00
... Peptide Therapeutics, Peptide Vaccine & Peptide Hormone Global Peptide Therapeutics Market Dynamics Global Peptide Clinical Pipeline by Company, Indication & Phase Global Peptide Pipeline: 722 Peptides Majority Peptides in Preclinical Phase: 308 Peptides Commercially Available Peptides: 136 Peptides ...
January 2020
1500 pages
Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2019–2026
US$ 5,370.00
... the players operating in this market. The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes ...
January 2020
239 pages
Proton Therapy in Cancer: Global Markets
US$ 5,500.00
REPORT SCOPE: BCC Research’s new report, “Proton Therapy in Cancer: Global Markets,” provides a comprehensive analysis of the proton therapy market in global context, including market forecasts and...
December 2019
185 pages
Therapeutic Proteins Global Market Report 2020. Including: 1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone 2) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others. Covering: Abbott Laboratories, Amgen Inc, Baxter International Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd
US$ 4,000.00
If ordered it will be delivered within 3-5 business days. Therapeutic Proteins Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with...
December 2019
200 pages
Dermatologicals in Hong Kong, China
US$ 990.00
... The humidity and high levels of air pollution seen in Hong Kong have been associated with skin problems, including inflammatory or allergic ... to have a negative impact on skin health. Euromonitor International's Dermatologicals in Hong Kong, China report offers a comprehensive guide to the size and shape of the ...
November 2019
21 pages
Allergic Rhinitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
166 pages
Urinary Incontinence - Pipeline Review, H2 2019
US$ 2,000.00
... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2019
72 pages
Endometriosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
134 pages
Bronchitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
129 pages
Cystic Fibrosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
489 pages
Polycystic Ovarian Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... . The Polycystic Ovarian Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Ovarian Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
50 pages
Sinusitis - Pipeline Review, H2 2019
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
117 pages
Anal Cancer - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
475 pages
Choroidal Neovascularization - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
57 pages
Pulmonary Arterial Hypertension - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Pulmonary Arterial Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
364 pages
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2019
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
88 pages
Acromegaly - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
102 pages
Alopecia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
184 pages
Anthrax - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
110 pages
Cough - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
99 pages
Glomerulonephritis - Pipeline Review, H2 2019
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
281 pages
Neutropenia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Neutropenia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
131 pages
Ocular Hypertension - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
144 pages
Fragile X Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... . The Fragile X Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fragile X Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
172 pages
Hyperuricemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Hyperuricemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperuricemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
85 pages
Tinnitus - Pipeline Review, H2 2019
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
48 pages
Bacterial Conjunctivitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bacterial Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
31 pages
Myocardial Infarction - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Myocardial Infarction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Infarction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
332 pages
Myocardial Ischemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
87 pages
Rectal Cancer - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
186 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
137 pages
Dementia - Pipeline Review, H2 2019
US$ 2,000.00
... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
371 pages
Insulin Resistance - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
48 pages
Thalassemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
207 pages
Leiomyosarcoma - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Leiomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
528 pages
